Mens Health Diagnostics Market - Global Forecast 2026-2032

The Mens Health Diagnostics Market is undergoing significant transformation, as technology, regulatory shifts, and evolving healthcare delivery models shape new standards and requirements. Senior executives and decision-makers can leverage focused insights from this report to navigate procurement, adoption, and innovation strategies in a complex, rapidly changing environment.

Market Snapshot: Mens Health Diagnostics Market Overview

The Mens Health Diagnostics Market expanded from USD 16.27 billion in 2025 to USD 18.15 billion in 2026. With an ongoing compound annual growth rate (CAGR) of 11.69%, the sector is poised to reach USD 35.29 billion by 2032. This positive growth reflects increasing demand for advanced diagnostic solutions and a heightened focus on early disease identification and improved patient outcomes across global healthcare systems.

Scope & Segmentation of the Mens Health Diagnostics Market

This report examines the strategic elements influencing the Mens Health Diagnostics Market, emphasizing the main product categories, applications, user profiles, technologies, and geographic regions that shape competitive positioning and operational differentiation.

Product Types: Includes imaging systems such as computed tomography, magnetic resonance imaging, nuclear imaging, ultrasound, and X-ray. Laboratory diagnostics like biomarker assays and genetic testing are analyzed for their role in early detection and tailored care.
End Users: Hospitals, diagnostic centers, clinics, and ambulatory surgical centers each present varied procurement priorities, operational protocols, and requirements for service delivery models.
Applications: Cardiovascular diagnostics, diabetes monitoring, prostate cancer diagnostics, and urological disorder diagnostics are tailored to meet the needs of disease-specific care pathways and distinct regulatory challenges.
Regional Markets: The Americas, Europe Middle East & Africa, and Asia-Pacific each reflect unique infrastructure maturity, healthcare funding mechanisms, and clinical practice standards influencing technology adoption.
Technologies: High-resolution imaging, molecular assays, and artificial intelligence-driven workflows support advanced clinical decision-making, greater provider efficiency, and improved patient stratification.
Care Settings: Adapting to point-of-care models, centralized laboratories, and hybrid care environments positions stakeholders for greater flexibility and scalability in evolving market scenarios.

Key Takeaways for Senior Decision-Makers

Diagnostics solutions now integrate clinical effectiveness, operational alignment, and compliance demands, making value-based care more attainable across delivery settings.
Technological convergence, including the synergy of imaging and laboratory data, facilitates timely identification of conditions and enables precision in clinical management strategies.
Artificial intelligence and cloud-based platforms continue to broaden diagnostic reach, automating frequent tasks and supporting decentralized care delivery models in large-scale networks.
Strategic procurement now emphasizes modular product architectures, localized consumables, and stronger supply chains to address changing market conditions and evolving policies.
Regional factors shape adoption rates, with established payer models and healthcare infrastructure accelerating uptake in the Americas, while Asia-Pacific regions prioritize scalable and cost-efficient solutions.
Competitive advantage relies increasingly on integrated service models and validated software analytics, tailored to diverse and complex healthcare ecosystems.

Tariff Impact: Adjusting to 2025 Trade Policy Changes

The 2025 trade policy shifts have led to consistent cost pressure for manufacturers, health systems, and suppliers in the Mens Health Diagnostics Market. These conditions prompt a reassessment of sourcing, with firms exploring regionalization, nearshoring, and adjusted contract negotiations to better balance risks and ensure continuity of supply.

Procurement now factors in logistics volatility, customs duties, and inventory holding costs when evaluating total cost of ownership.
Designing modular products and localizing consumables serve as practical approaches to reduce the impact of tariffs on imported volumes.
Protectionist trade measures and regulatory changes are impacting capital equipment investments, with organizations extending asset lifespans or renegotiating service contracts where needed.

Methodology & Data Sources

This analysis is based on direct interviews with clinicians, procurement leaders, health executives, and diagnostics developers, complemented by comprehensive secondary research in peer-reviewed literature and regulatory guidance. Together, these sources validate market drivers and maintain strategic credibility.

Mens Health Diagnostics Market: Why This Report Matters

Provides a unified framework connecting technological advancement with operational and regulatory requirements, supporting informed procurement and innovation decisions.
Delivers actionable intelligence on market segmentation, evolving trends, and their influence on commercialization and adoption strategies for senior stakeholders.

By translating market data and clinical insights into practical recommendations, this report positions decision-makers to drive effective planning and continued success in a dynamic diagnostic landscape.

Conclusion

Use this report to optimize product strategies, guide procurement processes, and support innovation adoption. The actionable intelligence presented empowers leaders to remain resilient and agile amid shifting market dynamics.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Mens Health Diagnostics Market, by Product Type

8.1. Imaging Systems
8.1.1. Computed Tomography
8.1.2. Magnetic Resonance Imaging
8.1.3. Nuclear Imaging
8.1.4. Ultrasound
8.1.5. X Ray
8.2. Laboratory Tests
8.2.1. Biomarker Assays
8.2.2. Genetic Testing

9. Mens Health Diagnostics Market, by Application

9.1. Cardiovascular Diagnostics
9.2. Diabetes Monitoring
9.3. Prostate Cancer Diagnostics
9.4. Urological Disorder Diagnostics

10. Mens Health Diagnostics Market, by End User

10.1. Ambulatory Surgical Centers
10.2. Clinics
10.3. Diagnostic Centers
10.4. Hospitals

11. Mens Health Diagnostics Market, by Region

11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific

12. Mens Health Diagnostics Market, by Group

12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO

13. Mens Health Diagnostics Market, by Country

13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea

14. United States Mens Health Diagnostics Market
15. China Mens Health Diagnostics Market

16. Competitive Landscape

16.1. Market Concentration Analysis, 2025
16.1.1. Concentration Ratio (CR)
16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025
16.5. Abbott Laboratories
16.6. Becton Dickinson and Company
16.7. Bio-Rad Laboratories, Inc.
16.8. bioMérieux SA
16.9. Danaher Corporation
16.10. DiaSorin S.p.A.
16.11. Exact Sciences Corporation
16.12. F. Hoffmann-La Roche Ltd
16.13. Hologic, Inc.
16.14. Johnson & Johnson
16.15. Koninklijke Philips N.V.
16.16. Myriad Genetics, Inc.
16.17. QIAGEN N.V.
16.18. Quest Diagnostics Incorporated
16.19. Siemens Healthineers AG
16.20. Sysmex Corporation
16.21. Thermo Fisher Scientific Inc.

List of Figures

FIGURE 1. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 11. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X RAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X RAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BIOMARKER ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BIOMARKER ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BIOMARKER ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIABETES MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIABETES MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIABETES MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY UROLOGICAL DISORDER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY UROLOGICAL DISORDER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY UROLOGICAL DISORDER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 85. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 86. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 87. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 97. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 98. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 99. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 111. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 112. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 117. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 118. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 129. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 130. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 135. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 136. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 140. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 141. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 142. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 146. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 147. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 148. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 149. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 152. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 154. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
TABLE 155. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Mens Health Diagnostics market report include:

Abbott Laboratories
Becton Dickinson and Company
Bio-Rad Laboratories, Inc.
bioMérieux SA
Danaher Corporation
DiaSorin S.p.A.
Exact Sciences Corporation
F. Hoffmann-La Roche Ltd
Hologic, Inc.
Johnson & Johnson
Koninklijke Philips N.V.
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific Inc.

Table Information

Report Attribute	Details
No. of Pages	191
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 18.15 Billion
Forecasted Market Value ( USD ) by 2032	$ 35.29 Billion
Compound Annual Growth Rate	11.6%
Regions Covered	Global
No. of Companies Mentioned	18

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Mens Health Diagnostics Market Overview

Scope & Segmentation of the Mens Health Diagnostics Market

Key Takeaways for Senior Decision-Makers

Tariff Impact: Adjusting to 2025 Trade Policy Changes

Methodology & Data Sources

Mens Health Diagnostics Market: Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Prostate Cancer Diagnostics Market - Global Forecast 2026-2032

Autoimmune Disease Diagnostics Market - Global Forecast 2026-2032

Prostate Specific Antigen (Psa) Test Market Outlook 2025-2034: Market Share, and Growth Analysis

Cancer Diagnostics Market - Technologies, Applications and End-Use Facilities

Prostate Specific Antigen (PSA) Test Market Report 2025